| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 167 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 151 |
| 2 | TACROLIMUS OINTMENT 0.1% | 151 |
| 3 | PREDNISONE | 149 |
| 4 | PREDNISOLONE | 131 |
| 5 | PREDNISOLONE ORAL | 131 |
| 6 | PREDNISOLONE ORAL SOLUTION | 131 |
| 7 | METHOTREXATE SODIUM | 124 |
| 8 | METHOTREXATE | 109 |
| 9 | MYCOPHENOLATE MOFETIL | 103 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | WATER, PURIFIED | 1 | 0.1111 |
| 1 | AVOBENZONE, OCTINOXATE, AND WHITE PETROLATUM | 1 | 0.0400 |
| 2 | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | 1 | 0.0244 |
| 3 | MILTEFOSINE | 5 | 0.0129 |
| 4 | THROMBIN HUMAN AND FIBRINOGEN | 3 | 0.0089 |
| 5 | TRILACICLIB | 2 | 0.0082 |
| 6 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 7 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 8 | IBERDOMIDE | 1 | 0.0067 |
| 9 | ANIDULAFUNGIN | 10 | 0.0061 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 423 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 135 |
| 2 | Platinum-based Drug [EPC] | 132 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 129 |
| 4 | Kinase Inhibitor [EPC] | 114 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 112 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 100 |
| 7 | Microtubule Inhibitor [EPC] | 89 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 85 |
| 9 | Azole Antifungal [EPC] | 81 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 5 | 0.0129 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 26 | 0.0044 |
| 2 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 4 | Echinocandin Antifungal [EPC] | 25 | 0.0030 |
| 5 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 6 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 135 | 0.0014 |
| 8 | Antimalarial [EPC] | 14 | 0.0013 |
| 9 | Antiprotozoal [EPC] | 14 | 0.0013 |